Back to Results
First PageMeta Content
Oncology / Olaparib / Ovarian cancer / BRCA mutation / Gemcitabine / Breast cancer / End point of clinical trials / Medicine / Organofluorides / Chemistry


FDA ODAC Briefing Document NDA[removed]Olaparib
Add to Reading List

Open Document

File Size: 509,78 KB

Share Result on Facebook
UPDATE